JPRN-UMIN000017995已完成未知
Evaluation of the combination effects of silodosin and dutasteride in patients with urination disorders associated with benign prostatic hyperplasia - Evaluation of the combination effects of silodosin and dutasteride in patients with urination disorders associated with benign prostatic hyperplasia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
This study was terminated because of temporary shipping adjustment of dutasteride.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Patients have any of the contraindications listed in the package inserts for silodosin, tamsulosin hydrochloride, or dutasteride. 2) Patients have prostate cancer. 3) Patients have lower urinary tract symptoms possibly due to urinary tract infection or neurogenic bladder.
研究者
相似试验
已完成
不适用
Α Prospective Observational Study for the Evaluation of Disease Control and Quality of Life in Patients With Benign PROStatic hyPERplasia Under Fixed Dose combΙnaTion Treatment With Dutasteride and Tamsulosin . PROSPERITY Group of Studies (I&II)Benign Prostatic HyperplasiaNCT04831476Elpen Pharmaceutical Co. Inc.1,296
已完成
2 期
Study of Silodosin to Facilitate Passage of Urinary StonesKidney StonesUrolithiasisUreteral CalculiNCT01144949Watson Pharmaceuticals239
已完成
3 期
Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination TreatmentProstatic HyperplasiaNCT00090103GlaxoSmithKline4,844
已完成
不适用
ong-term effect of dutasteride as add-on therapy for benign prostatic hyperplasia with persistent overactive bladder symptoms after treatment of alpha-1 blockerBenign prostatic hyperplasiaJPRN-UMIN000032082Hokkaido Prefectural Esashi Hospital70
已完成
4 期
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In MenNeoplasms, ProstateNCT00363311GlaxoSmithKline302